Close Menu

NEW YORK (GenomeWeb) – Natera today provided preliminary financial guidance for fiscal years 2015 and 2016.

The San Carlos, California-based molecular diagnostic company said it expects 2015 revenues to be in the range of $175 million to $190 million, 10 percent to 20 percent higher than its 2014 revenues of $159.3 million. It said it expects 2016 revenues to be in the range of $220 million to $240 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.